Anpario (LON:ANP) Sets New 12-Month High – Still a Buy?

Anpario plc (LON:ANP)’s stock price hit a new 52-week high on Monday . The company traded as high as GBX 488.55 ($6.18) and last traded at GBX 469 ($5.94), with a volume of 134166 shares traded. The stock had previously closed at GBX 463 ($5.86).

Analysts Set New Price Targets

Separately, Canaccord Genuity Group raised their price target on shares of Anpario from GBX 380 ($4.81) to GBX 500 ($6.33) and gave the company a “buy” rating in a report on Tuesday, January 14th.

Anpario Price Performance

The stock has a market capitalization of £80.01 million, a P/E ratio of 25.90 and a beta of 0.58. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15. The firm has a fifty day moving average price of GBX 417.98 and a two-hundred day moving average price of GBX 349.58.

Insider Activity at Anpario

In other Anpario news, insider Karen Prior sold 14,000 shares of the stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.81), for a total value of £53,200 ($67,324.73). 30.51% of the stock is owned by company insiders.

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.